Genentech’s parent company Roche said the $850m deal lines up with its plan to focus on three therapeutic areas including ...
RHHBY has strengthened its pipeline with an agreement to acquire Regor's portfolio of next-generation CDK inhibitors for the treatment of breast cancer.
Genentech has acquired Regor Pharmaceuticals’ next-generation CDK inhibitors for breast cancer treatment in a deal worth ...
Genentech to buy Regor's portfolio of next-generation CDK inhibitors to treat breast cancer: Cambridge, Massachusetts Tuesday, October 1, 2024, 10:00 Hrs [IST] Regor Pharmaceutica ...
8hon MSN
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...
Israeli troops crossed the border for the first time since 2006 in a ground operation targeting Hezbollah. The Israeli military called for evacuations in southern Lebanon. As a Crisis Builds ...
The Australian Red Cross says demand for blood is at a 12-year high as it launches the trial of a new pop-up donor centre in regional Western Australia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback